'Treatment status' presentation slideshows

Development Economics ECON 4915 Lecture 5

Development Economics ECON 4915 Lecture 5. Andreas Kotsadam. Outline. Seminar 3 Empirical methods Randomisation Other methods: IV, DD, DDD, RD. Discussion: Internal vs. External validity. Possible exam question on insurance and recap from last lecture. Seminar 3.

867 views • 72 slides

Why use The Great Plains Laboratory?

The Great Plains Laboratory has performed more than 100,000 tests of persons on the autistic spectrum throughout the world. Free consultation with testing by phone/Skype 2 autistic children of Great Plains employees have completely recovered using suggestions of Great Plains

837 views • 58 slides

Outline

Outline. General endpoint considerations Surrogate endpoints Composite endpoints and recurrent events Safety outcomes (adverse events). Outline . Some background Definitions Data collection considerations Reporting of safety outcomes Recommendations. Safety Outcomes: Some Viewpoints.

598 views • 50 slides

Gabe Avakian Orona, M.P.H. CAIR 2016 November 17, 2016

Gabe Avakian Orona, M.P.H. CAIR 2016 November 17, 2016. Leveraging the Power of Regression Discontinuity Designs for Program Evaluation: An Institutional Simulation Using R. Goals for today:. Introduce Regression Discontinuity Design (RDD) Introduce R Simulate an RDD using R

509 views • 50 slides

Heckle and Chide: Empowering matatu passengers to enforce better driving behavior in Kenya

Heckle and Chide: Empowering matatu passengers to enforce better driving behavior in Kenya. James Habyarimana Georgetown University and William Jack Georgetown University. Motivation.

535 views • 35 slides

HIV RISK REDUCTION AND SUBSTANCE ABUSE TREATMENT

HIV RISK REDUCTION AND SUBSTANCE ABUSE TREATMENT. George E. Woody, M.D. Department of Psychiatry, University of Pennsylvania and Department of Veterans Affairs, Philadelphia, PA. Overview of HIV Rise in NYC Among IDUs (Kreek et al). 1978-1984: Increase from 0 to about 55% overall

532 views • 35 slides

Mexico: School-Based Management

Mexico: School-Based Management. Paul Gertler Harry Anthony Patrinos Marta Rubio-Codina. Motivation. Increasing number of projects with School-Based Management (SBM) components Relatively little evidence being produced on outcomes

420 views • 27 slides

A Clinical Trial Sketch: VEGF in the Treatment of AMD

A Clinical Trial Sketch: VEGF in the Treatment of AMD. The Retina,Macula and Fovea. The Fovea Centralis ( http://hyperphysics.phy-astr.gsu.edu/hbase/vision/retina.html#c2 ). The retina is the light sensing portion of the eye. The macula is a portion of the retina that provides

395 views • 25 slides

Making the Most out of Discontinuities

Presented by Malte Lierl (Yale University). Making the Most out of Discontinuities. Introduction. How do we measure program impact when random assignment is not possible ? e.g. universal take-up non-excludable intervention treatment already assigned Solutions

315 views • 20 slides

Treatment Heterogeneity

Treatment Heterogeneity. Cheryl Rossi VP BioRxConsult , Inc. What is Heterogeneity of Treatment Effects (HTE). Heterogeneity of Treatment Effects implies that different patients can respond differently to a particular treatment.

294 views • 13 slides

Key Cite Shepards cont.

215 views • 13 slides